Table 2.
Comparing different clinical and laboratory outcomes between two groups
| Outcomes | Groups | F (P value) * | SMD [95 % CI] | Adjusted R 2 | |
|---|---|---|---|---|---|
| IS (n =80) | Control (n =80) | ||||
| SpO2 (Free air) (%) | 90.11 ± 5.9 | 90.10 ± 6.9 | 0.0 (0.99) a | 0.00 [-.31, .31] | 0.006 |
| 8.07 (0.00) b | 0.10 [-.21, .41] | 0.152 | |||
| SpO2 (With O2 therapy) (%) | 95.83 ± 5.22 | 95.89 ± 5.09 | 0.01 (0.94) a | -0.01 [-.32, .3] | -0.006 |
| 6.73 (0.00) b | 0.06 [-.25, .37] | 0.126 | |||
| pCO2 (mmHg) | 49.79 ± 7.71 | 50.1 ± 9.87 | 0.05 (0.83) a | -0.03 [-.35, .28] | -0.006 |
| 1.53 (0.2) b | -0.04 [-.35, .27] | 0.013 | |||
| pH | 7.40 ± 0.04 | 7.40 ± .05 | 0.37 (0.05) a | -0.1 [-.41, .22] | -0.004 |
| 0.76 (0.55) b | -0.09 [-.4, .22] | -0.006 | |||
| HCO3 (mEq/L) | 33.92 ± 3.69 | 30.71 ± 4.44 | 0.57 (0.45) a | -0.12 [-.43, .19] | -0.003 |
| 0.40 (0.80) b | -0.13 [.18, -.45] | -0.026 | |||
| RR (number/minute) | 23.45 ± 5.92 | 23.73 ± 5.73 | 0.09 (0.77) a | -0.05 [-.36, .26] | -0.006 |
| 2.18 (0.07) b | -0.09 [-.41, .21] | 0.029 | |||
| Modified Borg Scale at rest | 1.46 ± 2.42 | 1.75 ± 2.89 | 0.47 (0.49) a | -0.11 [-.42, .2] | -0.003 |
| 6.14 (0.00) b | -0.18 [-.49, .13] | 0.114 | |||
| Modified Borg Scale after activity | 3.24 ± 3.11 | 3.1 ± 3.4 | 0.08 (0.77) a | 0.05 [-.26, .36] | -0.006 |
| 3.91 (0.00) b | -0.02 [-.33, .29] | 0.068 | |||
| Length of stay (day) | 6.5± 5.34 | 7.01 ± 4.84 | 0.40 (0.53) a | -0.1 [-.21, .41] | -0.004 |
| 4.88 (0.001) b | -0.2 [-.51, .11] | 0.089 | |||
Data are expressed as mean ± standard deviation. IS: Incentive Spirometer; RR: respiratory rate; pCO2: Mixed venous CO2 pressure; SpO2: Oxygen saturation; CI: Confidence interval; SMD: Standardized mean difference (based on Cohen’s d test), ANOVA: Analysis of variance, ANCOVA: Analysis of covariance.
*Analyzed using ANOVA/ANCOVA tests. a Crude analysis; b Adjusted to baseline measurement of the D-dimer, CRP, and CT-score (as covariances).